Skip to menu Skip to content Skip to footer
Professor Hemamali Samaratunga
Professor

Hemamali Samaratunga

Email: 

Overview

Background

Hemamali Samaratunga MBBS (Hons) LRCP (London) MRCS (UK) FRCPA, FRCPath

  • Specialist Anatomical Pathologist, Managing Director, Aquesta Specialised Uropathology
  • Full Professor, University of Queensland Faculty of Medicine
  • Visiting Medical Officer, Greenslopes Private Hospital

Hemamali graduated with honours from the University of Sri Lanka, Colombo Medical School and completed Pathology specialty training in Queensland. She held a number of consultant posts in both hospital and private practice. In 2008 she established Aquesta Uropathology which now provides diagnostic uropathology services to the majority of urologists in Queensland and Northern New South Wales. In addition to this she maintains a large second opinion consultation practice with requests obtained from throughout Australia and from overseas.

She is active in Genitourinary Pathology research with collaborators in Australia, USA, Canada, Karolinska Institute in Sweden and the Wellington School of Medicine in New Zealand. She held the position of Secretary of the International Society of Urological Pathology from 2015 to 2019.

She was a contributor to the 2004, 2015 and 2022 World Health Organization (WHO) books on Classification of Tumours: Pathology and Genetics of Tumours of the Urinary and Male Reproductive System. She participated in the 2015 revision of the WHO Tumour Classification in Zurich, Switzerland (4th edition) as member, Prostate Tumour Panel. She was a representative of the Expert Groups formulating structured reporting protocols for the Royal College Pathologists of Australasia on kidney, testis and prostate cancer and is currently chairperson of the structured reporting protocols for Genitourinary cancer. She is also currently the Convener for the RCPA Uropathology Quality Assurance Program.

Qualifications

MBBS (HONS) LRCP (London) MRCS (UK) FRCPA FRCPath

Current UQ Appointments

Academic Title-Professor

Non-UQ Appointments

2008 - current: Specialist Anatomical Pathologist & Managing Director, Aquesta Specialized Uropathology

2015 - Current: Visiting Medical Officer, Greenslopes Private Hospital

2003 - 2021: Visiting Medical Officer, Princess Alexandra Hospital

June 2001 - Oct 2008: Specialist Anatomical Pathologist, Sullivan Nicolaides Pathology, Brisbane

1993 - 1997: Specialist Anatomical Pathologist, Royal Brisbane Hospital

1998 - 2001: Senior Anatomical Pathologist, North Brisbane Hospitals Board

Research Interests

  • Granular tumour necrosis
  • Diagnosis of limited adenocarcinoma on prostate needle biopsy
  • Ductal adenocarcinoma of prostate
  • Mucinous adenocarcinoma of prostate
  • Radical prostatectomy handling and reporting
  • Micropapillary urothelial cancer
  • Mimics of bladder cancer

Awards and other Esteem Indicators

2017 Admitted to Fellowship of the Royal College of Pathologists, London (FRC Path) for sustained excellence in published works

2022 Awarded the Grawitz Medal of the International Society of Urological Pathology for distinguished service to the discipline of Urological Pathology

2023 Author of the publication Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: Ten year data from the TROG 03.04 RADAR Trial. Pathology 54: 49- 54, awarded the prize of

Article of the Year by the Royal College of Pathologists of Australasia.

2024 Distinguished Fellowship Award of the Royal College Pathologists of Australasia

For distinguished service to the discipline of Urological Pathology

Keywords

Pathology, Genitourinary cancer, Prostate, Kidney, Urinary tract, Testis, Penis

Availability

Professor Hemamali Samaratunga is:
Available for supervision

Research impacts

She has over 320 scientific publications and has a Google Scholar H-index of 56 with 18150 citations. To date she has authored or co-authored 28 books, 21 book chapters and 274 peer-reviewed publications. Apart from her primary research activities Professor Samaratunga actively collaborates with other research groups and is a regular contributor - often as primary or senior author to international research consortia. One notable contribution has been her involvement in the development of artificial intelligence programs for the reporting of prostate cancer. In collaborative studies involving colleagues from the Netherlands, Sweden, Australia, New Zealand and the United States she was chosen to be one of three expert pathologists to review all cases, thus setting the gold standard for the diagnosis and grading of prostate cancer. These studies have been published in highly prestigious journals as noted in her CV. Importantly in comparative studies, the AI program informed by the findings of group of three pathologists that included Professor Samaratunga, outperformed all other AI programs.

Works

Search Professor Hemamali Samaratunga’s works on UQ eSpace

294 works between 1988 and 2024

81 - 100 of 294 works

2019

Journal Article

Intraductal carcinoma of the prostate: a critical re-appraisal

Varma, Murali, Delahunt, Brett, Egevad, Lars, Samaratunga, Hemamali and Kristiansen, Glen (2019). Intraductal carcinoma of the prostate: a critical re-appraisal. Virchows Archiv, 474 (5), 525-534. doi: 10.1007/s00428-019-02544-6

Intraductal carcinoma of the prostate: a critical re-appraisal

2019

Journal Article

Utility of cytokeratin 7, S100A1 and caveolin-1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma

Ng, Keng Lim, Ellis, Robert J., Samaratunga, Hemamali, Morais, Christudas, Gobe, Glenda C. and Wood, Simon T. (2019). Utility of cytokeratin 7, S100A1 and caveolin-1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma. Translational Andrology and Urology, 8 (S2), S123-S137. doi: 10.21037/tau.2018.11.02

Utility of cytokeratin 7, S100A1 and caveolin-1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma

2019

Journal Article

The International Society of Urological Pathology Education web-a web-based system for training and testing of pathologists

Egevad, Lars, Delahunt, Brett, Samaratunga, Hemamali, Leite, Katia R. M., Efremovs, Gennady, Furusato, Bungo, Han, Ming, Jufe, Laura, Tsuzuki, Toyonori, Wang, Zhe, Hornblad, Jonas and Clements, Mark (2019). The International Society of Urological Pathology Education web-a web-based system for training and testing of pathologists. Virchows Archiv, 474 (5), 577-584. doi: 10.1007/s00428-019-02540-w

The International Society of Urological Pathology Education web-a web-based system for training and testing of pathologists

2019

Conference Publication

Disruption of spermatogenesis and infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2)

Fogel, Brent, Becherel, Olivier, Zeitlin, Scott, Samaratunga, Hemamali, Greaney, Jessica, Homer, Hayden and Lavin, Martin (2019). Disruption of spermatogenesis and infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2). AAN 71st Annual Meeting, Philadelphia, PA United States, 4-10 May 2019. Philadelphia, PA United States: Wolters Kluwer. doi: 10.1212/wnl.92.15_supplement.p4.7-003

Disruption of spermatogenesis and infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2)

2019

Conference Publication

Disruption of spermatogenesis and infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2)

Fogel, Brent, Becherel, Olivier, Zeitlin, Scott, Samaratunga, Hemamali, Greaney, Jessica, Homer, Hayden and Lavin, Martin (2019). Disruption of spermatogenesis and infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2). 71st Annual Meeting of the American-Academy-of-Neurology (AAN), Philadelphia, PA, United States, 4-10 May 2019. Philadelphia, PA, United States: Lippincott Williams & Wilkins.

Disruption of spermatogenesis and infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2)

2019

Journal Article

Outcomes of primary lymph node staging of intermediate and high risk prostate cancer with 68Ga-PSMA positron emission tomography/computerized tomography compared to histological correlation of pelvic lymph node pathology

Yaxley, John W., Raveenthiran, Sheliyan, Nouhaud, François-Xavier, Samartunga, Hemamali, Yaxley, Anna J., Coughlin, Geoff, Delahunt, Brett, Egevad, Lars, McEwan, Louise and Wong, David (2019). Outcomes of primary lymph node staging of intermediate and high risk prostate cancer with 68Ga-PSMA positron emission tomography/computerized tomography compared to histological correlation of pelvic lymph node pathology. The Journal of Urology, 201 (4), 815-820. doi: 10.1097/JU.0000000000000053

Outcomes of primary lymph node staging of intermediate and high risk prostate cancer with 68Ga-PSMA positron emission tomography/computerized tomography compared to histological correlation of pelvic lymph node pathology

2019

Conference Publication

Assessing accuracy of multiparametric MRI and prostatic fusion biopsy in small targets utility of a target, near-target and MRI-negative biopsy schema in 34 patients

Gianduzzo, T. D., Samaratunga, H. and Gianduzzo, T. R. J. (2019). Assessing accuracy of multiparametric MRI and prostatic fusion biopsy in small targets utility of a target, near-target and MRI-negative biopsy schema in 34 patients. Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Brisbane Australia, Apr 13-16, 2019. HOBOKEN: WILEY.

Assessing accuracy of multiparametric MRI and prostatic fusion biopsy in small targets utility of a target, near-target and MRI-negative biopsy schema in 34 patients

2019

Conference Publication

The role of multiparametric MRI apparent diffusion co-efficient (ADC) values in prostate cancer grading and staging in men with PIRADS 3-5 mpMRI lesions

Raveenthiran, S., Yaxley, J., Brown, N., Parkinson, R. and Samaratunga, H. (2019). The role of multiparametric MRI apparent diffusion co-efficient (ADC) values in prostate cancer grading and staging in men with PIRADS 3-5 mpMRI lesions. Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Brisbane Australia, Apr 13-16, 2019. HOBOKEN: WILEY.

The role of multiparametric MRI apparent diffusion co-efficient (ADC) values in prostate cancer grading and staging in men with PIRADS 3-5 mpMRI lesions

2019

Journal Article

Evolution, controversies and the future of prostate cancer grading

Egevad, Lars, Delahunt, Brett, Yaxley, John and Samaratunga, Hemamali (2019). Evolution, controversies and the future of prostate cancer grading. Pathology International, 69 (2), 55-66. doi: 10.1111/pin.12761

Evolution, controversies and the future of prostate cancer grading

2019

Journal Article

Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded

Samaratunga, Hemamali, Delahunt, Brett, Egevad, Lars, Srigley, John R., Billis, Athanase, Bostwick, David G., Camparo, Philippe, Cheng, Liang, Clouston, David, Denham, James, Furusato, Bungo, Hartmann, Arndt, Jufe, Laura, Kench, James, Kenwright, Diane N., Kristiansen, Glen, Leite, Katia R.M., MacLennan, Gregory T., Merrimen, Jennifer, Moch, Holger, Oxley, Jon, Pan, Chin-Chen, Paner, Gladell, Ro, Jae, Sesterhenn, Isabell A. M., Shanks, Jonathan, Thunders, Michelle, Tsuzuki, Toyonori, Wheeler, Thomas ... Varma, Murali (2019). Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded. Pathology, 52 (2), 192-196. doi: 10.1016/j.pathol.2019.11.001

Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded

2019

Journal Article

Disruption of spermatogenesis and infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2)

Becherel, Olivier J., Fogel, Brent L., Zeitlin, Scott I., Samaratunga, Hemamali, Greaney, Jessica, Homer, Hayden and Lavin, Martin F. (2019). Disruption of spermatogenesis and infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2). Cerebellum, 18 (3), 448-456. doi: 10.1007/s12311-019-01012-w

Disruption of spermatogenesis and infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2)

2019

Journal Article

Datasets for the reporting of neoplasia of the testis: recommendations from the International Collaboration on Cancer Reporting

Berney, Dan M., Comperat, Eva, Feldman, Darren R., Hamilton, Robert J., Idrees, Muhammad T., Samaratunga, Hemamali, Tickoo, Satish K., Yilmaz, Asli and Srigley, John R. (2019). Datasets for the reporting of neoplasia of the testis: recommendations from the International Collaboration on Cancer Reporting. Histopathology, 74 (1), 171-183. doi: 10.1111/his.13736

Datasets for the reporting of neoplasia of the testis: recommendations from the International Collaboration on Cancer Reporting

2019

Journal Article

Risk of metastatic disease on 68gallium-prostate-specific membrane antigen positron emission tomography/computed tomography scan for primary staging of 1253 men at the diagnosis of prostate cancer

Yaxley, John W., Raveenthiran, Sheliyan, Nouhaud, François-Xavier, Samaratunga, Hemamali, Yaxley, William J., Coughlin, Geoff, Yaxley, Anna J., Gianduzzo, Troy, Kua, Boon, McEwan, Louise and Wong, David (2019). Risk of metastatic disease on 68gallium-prostate-specific membrane antigen positron emission tomography/computed tomography scan for primary staging of 1253 men at the diagnosis of prostate cancer. BJU International, 124 (3), 401-407. doi: 10.1111/bju.14828

Risk of metastatic disease on 68gallium-prostate-specific membrane antigen positron emission tomography/computed tomography scan for primary staging of 1253 men at the diagnosis of prostate cancer

2019

Conference Publication

Design and clinical validation of surface enhanced Raman spectroscopy nanodiagnostic technology for urinary prostate cancer risk prediction

Gardiner, F., Koo, K., Wang, J., Richards, R., Farrell, A., Yaxley, J., Samaratunga, H., Teloken, P., Roberts, M., Coughlin, G., Lavin, M., Mainwaring, P., Wang, Y., Gardiner, R. and Trau, M. (2019). Design and clinical validation of surface enhanced Raman spectroscopy nanodiagnostic technology for urinary prostate cancer risk prediction. Annual Scientific Meeting of the Urological Society of Australia and New-Zealand, Brisbane, QLD Australia, 13-16 April 2019. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Design and clinical validation of surface enhanced Raman spectroscopy nanodiagnostic technology for urinary prostate cancer risk prediction

2019

Journal Article

Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma

Dagher, Julien, Delahunt, Brett, Rioux-Leclercq, Nathalie, Egevad, Lars, Coughlin, Geoff, Dunglison, Nigel, Gianduzzo, Troy, Kua, Boon, Malone, Greg, Martin, Ben, Preston, John, Pokorny, Morgan, Wood, Simon and Samaratunga, Hemamali (2019). Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma. Histopathology, 74 (2), 284-290. doi: 10.1111/his.13737

Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma

2019

Journal Article

Grading of renal cell carcinoma

Delahunt, Brett, Eble, John N., Egevad, Lars and Samaratunga, Hemamali (2019). Grading of renal cell carcinoma. Histopathology, 74 (1), 4-17. doi: 10.1111/his.13735

Grading of renal cell carcinoma

2019

Journal Article

Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinoma

Dagher, Julien, Delahunt, Brett, Rioux-Leclercq, Nathalie, Egevad, Lars, Varma, Murali and Samaratunga, Hemamali (2019). Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinoma. Pathology, 51 (4), 349-352. doi: 10.1016/j.pathol.2019.01.004

Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinoma

2018

Journal Article

Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker

Sina, Abu Ali Ibn, Carrascosa, Laura G., Liang, Ziyu, Grewal, Yadveer S., Wardiana, Andri, Shiddiky, Muhammad J. A., Gardiner, Robert A., Samaratunga, Hemamali, Gandhi, Maher K., Scott, Rodney J., Korbie, Darren and Trau, Matt (2018). Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker. Nature Communications, 9 (1) 4915, 4915. doi: 10.1038/s41467-018-07214-w

Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker

2018

Journal Article

The current status of renal cell carcinoma and prostate carcinoma grading

Delahunt, Brett, Egevad, Lars, Yaxley, John and Samaratunga, Hemamali (2018). The current status of renal cell carcinoma and prostate carcinoma grading. International Braz J Urol, 44 (6), 1057-1062. doi: 10.1590/S1677-5538.IBJU.2018.06.01

The current status of renal cell carcinoma and prostate carcinoma grading

2018

Journal Article

MRI-guided in-bore biopsy for prostate cancer: what does the evidence say?: a case series of 554 patients and a review of the current literature

Pokorny, Morgan, Kua, Boon, Esler, Rachel, Yaxley, John, Samaratunga, Hemamali, Dunglison, Nigel, Gianduzzo, Troy, Coughlin, Geoff, Holt, Ross, Laing, Barbara, Ault, Darren, Brown, Nicholas, Parkinson, Rob and Thompson, Les (2018). MRI-guided in-bore biopsy for prostate cancer: what does the evidence say?: a case series of 554 patients and a review of the current literature. World Journal of Urology, 37 (7), 1263-1279. doi: 10.1007/s00345-018-2497-y

MRI-guided in-bore biopsy for prostate cancer: what does the evidence say?: a case series of 554 patients and a review of the current literature

Supervision

Availability

Professor Hemamali Samaratunga is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Professor Hemamali Samaratunga's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au